PD-13201-2

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePD-13201-2
Drug Alias NamePD-13201-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParke-Davis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis Corp
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A